by Jordana Choucair | Jan 11, 2022 | Access & Coverage
Enrollment in ACA plans reached 13.8 million for 2022, according to CMS, representing a 20 percent uptick from a comparable period last year ahead of the sign-up deadline this weekend. CMS Administrator Chiquita Brooks-LaSure said early data indicates that the largest...
by Jordana Choucair | Jan 10, 2022 | Life Sciences
Pfizer Inc. will pay up to $1.35 billion to partner with gene-editing specialist Beam Therapeutics Inc. The four-year deal will allow Pfizer to develop three drugs for rare genetic diseases of the liver, muscle, and central nervous system using base editing, a...
by Jordana Choucair | Jan 10, 2022 | Life Sciences
Moderna donated 2.7 million COVID-19 vaccine doses to Mexico as cases surge in the country. The donations arrived on Saturday at an airport in Toluca after the country this week surpassed more than 300,000 total confirmed coronavirus deaths. The government said the...
by Jordana Choucair | Jan 10, 2022 | Life Sciences
The FDA on Friday authorized adults 18 and older who are vaccinated with Moderna to get a booster shot five months after their second dose, shortening the waiting period by a month. Days earlier, the agency shortened the booster shot waiting period for everyone 12 and...
by Jordana Choucair | Jan 10, 2022 | D.C. News
The Biden administration will re-evaluate its decision to ship three types of monoclonal antibody treatments to states, after data showed that two of the three authorized antibodies may be ineffective against the omicron variant. David Kessler, chief scientific...
Recent Comments